Search
for

    Sort by

    Research 121–150 of 355

    1. Epigallocatechin-3 Gallate Inhibits STAT-1/JAK2/IRF-1/HLA-DR/HLA-B and Reduces CD8 MKG2D Lymphocytes of Alopecia Areata Patients 2018 · 15 citations
    2. Dermatologic Adverse Events from Cancer Treatments Springer eBooks · 2018 · 2 citations
    3. The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside Frontiers in immunology · 2020 · 144 citations
    4. Epidermal mammalian target of rapamycin complex 2 controls lipid synthesis and filaggrin processing in epidermal barrier formation Journal of Allergy and Clinical Immunology · 2019 · 34 citations
    5. Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics Journal of Inflammation Research · 2026
    6. Understanding, recognizing, and managing toxicities of targeted anticancer therapies Ca · 2013 · 278 citations
    7. Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails American Journal of Clinical Dermatology · 2018 · 179 citations
    8. Regulatory T cells in dominant immunologic tolerance Journal of Allergy and Clinical Immunology · 2023 · 26 citations
    9. Prophylaxis and Management of Skin Toxicities Breast care · 2019 · 15 citations
    10. Autophagy: Guardian of Skin Barrier Biomedicines · 2022 · 8 citations
    11. Medical Dermatology Australasian Journal of Dermatology · 2024 · 2 citations
    12. Inhaled Medicines for Targeting Non-Small Cell Lung Cancer Pharmaceutics · 2023 · 2 citations
    13. Global trends in tertiary lymphoid structures: a bibliometric analysis from 2014 to 2023 Frontiers in Immunology · 2024 · 1 citations
    14. Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology Clinical & Translational Oncology · 2026
    15. Repurposing existing drugs for the treatment ofCOVID-19/SARS-CoV-2: A review of pharmacological effects and mechanism of action Heliyon · 2024 · 2 citations
    16. Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy Journal of the American Academy of Dermatology · 2018 · 32 citations
    17. Folate receptor β performs an immune checkpoint function in activated macrophages Frontiers in Immunology · 2025 · 1 citations
    18. Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases Cell · 2020 · 227 citations
    19. Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System 2019 · 142 citations
    20. What’s Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses Frontiers in Immunology · 2020 · 125 citations
    21. Discrimination of Dysplastic Nevi from Common Melanocytic Nevi by Cellular and Molecular Criteria Journal of Investigative Dermatology · 2016 · 41 citations
    22. Malt1 Protease Is Critical in Maintaining Function of Regulatory T Cells and May Be a Therapeutic Target for Antitumor Immunity 2019 · 39 citations
    23. Poster Presentations Australasian Journal of Dermatology · 2021 · 25 citations
    24. Alopecia Areata: Updates from the Mouse Perspective 2013 · 8 citations
    25. Pathophysiology of Alopecia Areata in the Pediatric Patient Pediatric Dermatology · 2025 · 5 citations
    26. Regulation and dysregulation of hair regeneration: aiming for clinical application Cell Regeneration · 2022 · 2 citations
    27. Investigating the Genetic Association of Selected Candidate Loci with Alopecia Areata Susceptibility in Jordanian Patients Medicina · 2025 · 1 citations
    28. Genome-wide association study of atopic and autoimmune comorbidities in alopecia areata Frontiers in Immunology · 2026
    29. Multi-modal skin atlas identifies a multicellular immune-stromal community associated with disrupted cornification and specific T cell expansion in atopic dermatitis Nature Communications · 2026
    30. Review of Promising Off-Label Use of Deucravacitinib International Journal of Molecular Sciences · 2025